Cardioplegia IV Solution Recalled Due to Sterility Assurance Deficiency
Central Admixture Pharmacy Services has recalled Cardioplegia Solution due to lacking sterility assurance and insufficient validation data for decontamination cycles. The recall affects 148 bags distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall involving inadequate sterility assurance for a sterile injectable product. No reported illnesses, deaths, or injuries are documented. The score reflects the seriousness of a potential sterility defect in a critical-use injectable without confirmed harm.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling Cardioplegia Solution, 70 mEq K, Induction 8:1, a high potassium IV solution in 300 mL bags. The product (NDC: 72196-0214-1) was distributed nationwide in the USA. Two lot numbers are affected: Lot 36-253954 (expiration 7/20/2023) and Lot 36-256032 (expiration 7/28/2023). A total of 148 bags are subject to this recall.
The recall was initiated due to lack of assurance of sterility. The manufacturer has not provided adequate validation data for the decontamination cycles used in the sterilization process, raising concerns about whether the product is sterile and safe for use.
This product is an intravenous (IV) solution intended for use in hospital settings. Healthcare facilities, pharmacies, and medical professionals that received the affected lot numbers should be aware of this recall.
Healthcare facilities and medical professionals should immediately quarantine and discontinue use of the affected product lots. Anyone with questions or concerns should contact the FDA or the recalling manufacturer, Central Admixture Pharmacy Services, Inc.
The recalled product
- Product
- CARDIOPLEGIA SOLUTION, 70 mEq K, Induction 8:1, non-enriched, High Potassium, IV Bag, Total Volume = 300 mL, RX only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0214-1
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Hazard
- lack-of-sterility
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot: 36-253954
- Exp. 7/20/2023
- 36-256032
- Exp. 7/28/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27